|1.||Lin, Chen-Yong: 32 articles (01/2015 - 01/2002)|
|2.||Dickson, Robert B: 17 articles (11/2007 - 01/2002)|
|3.||Johnson, Michael D: 15 articles (01/2015 - 04/2002)|
|4.||List, Karin: 15 articles (01/2015 - 05/2002)|
|5.||Bugge, Thomas H: 11 articles (07/2012 - 05/2002)|
|6.||Szabo, Roman: 9 articles (08/2010 - 05/2002)|
|7.||Lee, Ming-Shyue: 8 articles (07/2015 - 08/2005)|
|8.||Wang, Jehng-Kang: 8 articles (01/2015 - 08/2008)|
|9.||Kataoka, Hiroaki: 7 articles (01/2015 - 09/2004)|
|10.||Bugge, T H: 5 articles (08/2015 - 04/2011)|
08/27/2015 - "Matriptase was congenitally and constitutively deregulated in our prior studies, and therefore it was unclear if aberrant matriptase signaling supports only initiation of tumor formation or if it is also critical for the progression of established tumors. "
11/15/2013 - "Both in vitro cell and in vivo animal studies indicate that these two molecular beacons are sensitive and specific for the detection of matriptase expression in the tumor, thereby paving the way to image the activities of this diagnostic protease in living organisms. "
08/01/2012 - "Taken together with our previous finding that matriptase is a proteolytic activator of PDGF D, this study provides a molecular insight into signal amplification of the proteolytic network and PDGF signaling loop during cancer progression."
07/12/2012 - "Several studies have reported deregulated matriptase expression in several types of epithelial cancers, suggesting that matriptase constitutes a potential target for cancer therapy. "
02/01/2009 - "This review summarizes current knowledge about matriptase and its role in cancer based on expression studies, biochemical characterization, cell-culture based studies and in vivo experiments."
08/01/2010 - "Ablation of matriptase from LEKTI-deficient mice dampened inflammation, eliminated aberrant protease activity, prevented detachment of the stratum corneum, and improved the barrier function of the epidermis. "
07/01/2012 - "Strategies to enhance matriptase-mediated barrier recovery could be important for intervening in the cycle of inflammation associated with IBD."
02/01/2015 - "Compounds such as 10, identified using a fragment-linking approach, can be explored further to understand the role of matriptase as a drug target in cancer and inflammation. "
03/01/2011 - "Although activated matriptase is not detected in normal epidermis, a dramatic increase is seen in keratinocytes at the site of inflammation in 16 different skin diseases. "
10/01/2007 - "The mutant embryos exhibited inflammation in areas of epidermal hyperproliferation that was rescued by knock-down of the type II transmembrane serine protease Matriptase 1 (also known as St14), suggesting a novel role for Hai1-Matriptase 1 pathway in regulating inflammation. "
10/31/2007 - "In conclusion, pharmacological inhibitors of matriptase may not be effective treatment for advanced colorectal adenocarcinomas."
08/01/2009 - "The aim of this study was to examine the role of matriptase in pancreatic ductal adenocarcinoma by expression analysis and functional assays in vitro. "
08/01/2009 - "Our findings demonstrate for the first time that matriptase may be involved in the progression of pancreatic ductal adenocarcinoma and that matriptase inhibition may contribute to preventing the progression of this devastating disease."
08/01/2009 - "Immunohistochemical analysis of matriptase performed on microtissue arrays and large samples of 55 pancreatic ductal adenocarcinomas and on 31 samples of normal pancreatic ducts revealed that although matriptase expression differed greatly in both malignant and normal ductal pancreatic tissue, matriptase scores were significantly (p=0.02) elevated in pancreatic ductal adenocarcinoma compared to normal pancreatic ducts. "
08/01/2009 - "Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma."
|4.||Prostatic Neoplasms (Prostate Cancer)
07/15/2015 - "Further, we determined that higher levels of TMPRSS2 expression correlate with higher levels of matriptase activation in prostate cancer tissues. "
04/03/2015 - "The oncogenic roles of PDGF-D and its proteolytic activator, matriptase, have been strongly implicated in human prostate cancer. "
08/01/2012 - "Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer."
02/01/2011 - "Proteolytic processing of Ln-332 by matriptase enhances speed and directional persistence of prostate cancer cells."
02/01/2011 - "Matriptase overexpressing LNCaP prostate cancer cells were generated and included in Transwell migration assays and single cell motility assays, along with other prostate cells. "
01/01/2008 - "The aim of this study was to examine the expression of matriptase and survivin in breast carcinoma and correlate with clinicopathological parameters. "
03/01/2003 - "Our studies demonstrate tight correlation between the expression of HGF, matriptase, and Met in breast carcinoma. "
01/01/2014 - "Some active matriptase is, however, rapidly shed to the extracellular milieu by these carcinoma cells. "
01/01/2012 - "In contrast, overexpression of matriptase in 4T1 mouse breast carcinoma cells resulted in visible changes in morphology, actin staining and cell to cell contacts. "
01/01/2012 - "In MDA-MB-231 human breast carcinoma cells the only noted consequence of matriptase overexpression was modestly impaired growth in vivo. "
|1.||Serine Proteases (Serine Protease)
|3.||Peptide Hydrolases (Proteases)
|4.||Messenger RNA (mRNA)
|7.||Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
|8.||Proteins (Proteins, Gene)
|10.||pro-hepatocyte growth factor
|1.||Heterologous Transplantation (Xenotransplantation)